HRTX Earnings

Quarterly EPS
$-0.06
Q2 2024
$-0.03
Q3 2024
$0.02
Q4 2024
$0.02
Q1 2025
$-0.02
Q2 2025
$-0.10
Q3 2025
$-0.02
Q4 2025
$-0.04
Q1 2026
Latest Revenue34.7M
Latest Net Income-8111000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.0434.7M-8111000-10.8%-300.0%
Q4 2025-$0.0240.6M-2954000-0.5%-200.0%
Q3 2025-$0.1038.2M-17495000+16.5%-233.3%
Q2 2025-$0.0237.2M-2381000+3.3%+66.7%
Q1 2025$0.0238.9M2.6M+12.2%+200.0%
Q4 2024$0.0240.8M3.7M+19.1%+133.3%
Q3 2024-$0.0332.8M-4848000+4.4%+82.4%
Q2 2024-$0.0636.0M-9235000+13.4%+82.9%
Q1 2024-$0.0234.7M-3160000
Q4 2023-$0.0634.2M-10724000
Q3 2023-$0.1731.4M-25008000
Q2 2023-$0.3531.8M-42059000
Heron Therapeutics (HRTX) — Earnings